Boston Medical Sciences

Tokyo, Japan · Founded 2023 · Privately Held (backing)

Developer of a non-invasive colorectal cancer detection platform designed to improve patient outcomes by leveraging data for decision-making. Boston Medical Sciences is based in Tokyo, Japan and was founded in 2023. Its last known valuation is $31 million. It has raised $9.2 million.

Last price · $/share
—
Implied valuation
$31.0M
Total raised
$9.2M
Last round
—

Who backs Boston Medical Sciences?

9 investors
InvestorType
Mitsubishi UFJ CapitalOther
Global BrainVenture capital
JIC Venture Growth InvestmentsVenture capital
Beyond Next VenturesVenture capital
Meiji Yasuda Life Insurance CompanyOther
CHCP—
Eukaria—
NEDO Entrepreneurs Program—
Takanawa Earth Benefit Fund—
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

Boston Medical Sciences investors

9 investors are on record for Boston Medical Sciences, including Mitsubishi UFJ Capital, Global Brain, JIC Venture Growth Investments and Beyond Next Ventures.

Free account
More of Boston Medical Sciences with a free account
  • ·Watch Boston Medical Sciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 9 firms already write checks for companies like Boston Medical Sciences. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View